Filing Details

Accession Number:
0001633970-15-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-03 17:29:17
Reporting Period:
2015-04-01
Filing Date:
2015-04-03
Accepted Time:
2015-04-03 17:29:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612230 Scott Houlton C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-01 56,290 $10.71 74,571 No 4 M Direct
Common Stock Disposition 2015-04-01 36,598 $30.61 37,973 No 4 F Direct
Common Stock Disposition 2015-04-01 14,827 $30.61 23,146 No 4 S Direct
Common Stock Acquisiton 2015-04-01 25,967 $10.71 49,113 No 4 M Direct
Common Stock Disposition 2015-04-01 16,883 $30.61 32,230 No 4 F Direct
Common Stock Acquisiton 2015-04-01 9,352 $18.57 41,582 No 4 M Direct
Common Stock Disposition 2015-04-01 7,373 $30.61 34,209 No 4 F Direct
Common Stock Disposition 2015-04-01 851 $30.61 33,358 No 4 S Direct
Common Stock Acquisiton 2015-04-01 6,426 $18.71 39,784 No 4 M Direct
Common Stock Disposition 2015-04-01 5,082 $30.61 34,702 No 4 F Direct
Common Stock Disposition 2015-04-01 575 $30.61 34,127 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2015-04-01 56,290 $0.00 56,290 $10.71
Common Stock Options to purchase common stock Disposition 2015-04-01 25,967 $0.00 25,967 $10.71
Common Stock Options to purchase common stock Disposition 2015-04-01 9,352 $0.00 9,352 $18.57
Common Stock Options to purchase common stock Disposition 2015-04-01 6,426 $0.00 6,426 $18.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-10-23 2019-10-23 No 4 M Direct
0 2010-10-23 2019-10-23 No 4 M Direct
8,148 2013-04-01 2022-05-25 No 4 M Direct
25,704 2014-06-25 2023-06-25 No 4 M Direct
Footnotes
  1. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
  2. These shares were sold in multiple transactions at prices ranging from $30.21 to $30.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. On October 23, 2009, the reporting person was granted an option to purchase 87,500 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010.
  4. On October 23, 2009, the reporting person was granted an option to purchase 29,260 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2010, 2011, 2012, 2013 and 2014. The performance criteria for 2010, 2011, 2012, 2013 and 2014 were met, resulting in vesting of 29,260 shares.
  5. On June 25, 2012, the reporting person was granted an option to purchase 17,500 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on April 1, 2013.
  6. On June 25, 2013, the reporting person was granted an option to purchase 32,130 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018. The performance criteria for 2014 were met, resulting in vesting of the option as to 6,426 shares.